| Valproic acid | Approved Investigational | BBS7 | 55212 |
upregulated | Valproic Acid results in increased expression of BBS7 mRNA | 4q27 | |
| Valproic acid | Approved Investigational | BBS9 | 27241 |
upregulated | Valproic Acid results in increased expression of BBS9 mRNA | 7p14.3 | |
| Valproic acid | Approved Investigational | BBX | 56987 |
downregulated | Valproic Acid results in decreased expression of BBX mRNA | 3q13.12 | |
| Valproic acid | Approved Investigational | BBX | 56987 |
upregulated | Valproic Acid results in increased expression of BBX mRNA | 3q13.12 | |
| Valproic acid | Approved Investigational | BCAN | 63827 |
upregulated | Valproic Acid results in increased expression of BCAN mRNA | 1q23.1 | |
| Valproic acid | Approved Investigational | BCAP29 | 55973 |
downregulated | Valproic Acid results in decreased expression of BCAP29 mRNA | 7q22.3 | |
| Valproic acid | Approved Investigational | BCAP31 | 10134 |
upregulated | Valproic Acid results in increased expression of BCAP31 mRNA | Xq28 | |
| Valproic acid | Approved Investigational | BCAR3 | 8412 |
upregulated | Valproic Acid results in increased expression of BCAR3 mRNA | 1p22.1 | |
| Valproic acid | Approved Investigational | BCAS4 | 55653 |
upregulated | Valproic Acid results in increased expression of BCAS4 mRNA | 20q13.13 | |
| Valproic acid | Approved Investigational | BCAT1 | 586 |
downregulated | Valproic Acid results in decreased expression of BCAT1 mRNA | 12p12.1 | |
| Valproic acid | Approved Investigational | BCCIP | 56647 |
upregulated | Valproic Acid results in increased expression of BCCIP mRNA | 10q26.2 | |
| Valproic acid | Approved Investigational | BCDIN3D | 144233 |
upregulated | Valproic Acid results in increased expression of BCDIN3D mRNA | 12q13.12 | |
| Valproic acid | Approved Investigational | BCHE | 590 |
downregulated | Valproic Acid results in decreased expression of BCHE mRNA | 3q26.1 | |
| Valproic acid | Approved Investigational | BCHE | 590 |
upregulated | Valproic Acid results in increased expression of BCHE mRNA | 3q26.1 | |
| Valproic acid | Approved Investigational | BCKDHB | 594 |
upregulated | Valproic Acid results in increased expression of BCKDHB mRNA | 6q14.1 | |
| Valproic acid | Approved Investigational | BCKDK | 10295 |
upregulated | Valproic Acid results in increased expression of BCKDK mRNA | 16p11.2 | |
| Valproic acid | Approved Investigational | BCL11A | 53335 |
downregulated | Valproic Acid results in decreased expression of BCL11A mRNA | 2p16.1 | |
| Valproic acid | Approved Investigational | BCL11A | 53335 |
upregulated | Valproic Acid results in increased expression of BCL11A mRNA | 2p16.1 | |
| Valproic acid | Approved Investigational | BCL11B | 64919 |
upregulated | Valproic Acid results in increased expression of BCL11B mRNA | 14q32.2 | |
| Valproic acid | Approved Investigational | BCL2 | 596 |
downregulated | Valproic Acid results in decreased expression of BCL2 mRNA | 18q21.33 | |
| Valproic acid | Approved Investigational | BCL2 | 596 |
upregulated | Valproic Acid results in increased expression of BCL2 mRNA | 18q21.33 | |
| Valproic acid | Approved Investigational | BCL2L1 | 598 |
upregulated | Valproic Acid results in increased expression of BCL2L1 mRNA | 20q11.21 | |
| Valproic acid | Approved Investigational | BCL2L11 | 10018 |
downregulated | Valproic Acid results in decreased expression of BCL2L11 mRNA | 2q13 | |
| Valproic acid | Approved Investigational | BCL2L14 | 79370 |
upregulated | Valproic Acid results in increased expression of BCL2L14 mRNA | 12p13.2 | |
| Valproic acid | Approved Investigational | BCL7A | 605 |
downregulated | Valproic Acid results in decreased expression of BCL7A mRNA | 12q24.31 | |